Zobrazeno 1 - 10
of 65
pro vyhledávání: '"L.F. Bouzas"'
Autor:
R. Tavares, C. Grecco, S. Lermontov, A. Seber, V. Zechin, V. Coulturato, A. Vigorito, Carmem Sales Bonfim, M. Flowers, J. Fernandes, R. Passos, L.F. Bouzas, N. Villela, L. Ribeiro, S. Nichele, Liane Esteves Daudt, Leonardo Javier Arcuri, R. Gouveia
Publikováno v:
Bone Marrow Transplantation
Autor:
W Bujan-Boza, Maria Marta Rivas, Derlis Gonzalez, Guillermo J Ruiz-Argüelles, Gregorio Jaimovich, A Kardus-Urueta, Marcelo C. Pasquini, D Ubidia, Robert Peter Gale, Sebastian Galeano, Julia Palma, Carmem Sales Bonfim, Adriana Seber, G Borelli, Oscar Gonzalez-Ramella, M Hernandez-Gimenez, David Gómez-Almaguer, Ignacio Hanesman, Alois Gratwohl, Dietger Niederwieser, Antonio Carrasco, J. Martínez Rolón, Yoshihisa Kodera, Helen Baldomero, L.F. Bouzas, José R. Nuñez, German Espino, Ernesto Fanilla, Jeff Szer, Michael Gratwohl
Publikováno v:
Bone marrow transplantation. 52(5)
Haematopoietic cell transplant activity in the 28 countries comprising Latin America is poorly defined. We conducted a voluntary survey of members of the Latin American Bone Marrow Transplantation Group regarding transplant activity 2009-2012. Collat
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
B. Du Rocher, L.F. Bouzas, Carolina Lazzarotto-Silva, Andre Luiz Mencalha, T. de Souza Fernandez, Luciana Pizzatti, Eliana Abdelhay, Renata Binato
Publikováno v:
Cell Proliferation. 46:10-22
Ex vivo expansion and manipulation of human mesenchymal stem cells are important approaches to immunoregulatory and regenerative cell therapies. Although these cells show great potential for use, issues relating to their overall nature emerge as prob
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Teresa de Souza Fernandez, Eliana Abdelhay, Luize Otero, Jane Dobbin, Alexandre Mello de Azevedo, L.F. Bouzas, Maria Helena Ornellas
Publikováno v:
Revista Brasileira de Cancerologia; Vol. 53 No. 4 (2007): Oct./Nov./Dec.; 405-410
Revista Brasileira de Cancerologia; Vol. 53 Núm. 4 (2007): oct./nov./dic.; 405-410
Revista Brasileira de Cancerologia; v. 53 n. 4 (2007): out./nov./dez.; 405-410
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
Revista Brasileira de Cancerologia, Vol 53, Iss 4 (2007)
Revista Brasileira de Cancerologia; Vol. 53 Núm. 4 (2007): oct./nov./dic.; 405-410
Revista Brasileira de Cancerologia; v. 53 n. 4 (2007): out./nov./dez.; 405-410
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
Revista Brasileira de Cancerologia, Vol 53, Iss 4 (2007)
Imatinibe induz à resposta citogenética completa em cerca de 80% dos pacientes diagnosticados com leucemia mielóide crônica (LMC) em fase crônica (FC), e em 41% dos pacientes em 1ª FC após falha do tratamento com interferon-α. Alguns paciente
Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease
Autor:
I.Z. Renault, S.C.M. Pereira, R.C.B.S. Tavares, D.G. Tabak, A.M.G. Lobo, N. Lorenzi, J.L. Ferreira, L.F. Bouzas, A.M. Azevedo, M.C. Nogueira, Decio Lerner
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 40, Iss 12, Pp 1623-1629 (2007)
Brazilian Journal of Medical and Biological Research, Volume: 40, Issue: 12, Pages: 1623-1629, Published: 29 OCT 2007
Brazilian Journal of Medical and Biological Research v.40 n.12 2007
Brazilian Journal of Medical and Biological Research
Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
Brazilian Journal of Medical and Biological Research, Volume: 40, Issue: 12, Pages: 1623-1629, Published: 29 OCT 2007
Brazilian Journal of Medical and Biological Research v.40 n.12 2007
Brazilian Journal of Medical and Biological Research
Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
Allogeneic stem cell transplantation has been increasingly performed for a variety of hematologic diseases. Clinically significant acute graft-versus-host disease (GVHD) occurs in 9 to 50% of patients who receive allogeneic grafts, resulting in high
Autor:
Gregorio Jaimovich, R Pasquini, M Nese, C.A. De Souza, Laura Samantha Galindo-Becerra, Raul Gabus, A J Karduss-Urueta, Nancy Labastida-Mercado, Celso Arrais-Rodrigues, L.F. Bouzas, Adriana Seber, David Gómez-Almaguer, Guillermo J Ruiz-Argüelles, Gustavo Dufort, J C Jaime-Fagundo, N Hammerschlak, V Abello-Polo
Publikováno v:
Bone marrow transplantation. 50(8)
Publications of bone marrow transplants in Latin America. A report of the Latin American Group of Bone Marrow Transplantation
Autor:
Ignacio Hanesman, Marcelo C. Pasquini, German Espino, Carmen Bonfim, Michael Gratwohl, G Borelli, A. Gratwohl, Sebastian Galeano, Dietger Niederwieser, Antonio Carrasco, M Hernandez-Gimenez, L.F. Bouzas, J. Martínez Rolón, Robert Peter Gale, Derlis Gonzalez, José R. Nuñez, David Gómez-Almaguer, W Bujan-Boza, Guillermo J Ruiz-Argüelles, Maria Marta Rivas, Jeff Szer, Adriana Seber, Gregorio Jaimovich, Yoshihisa Kodera, Oscar Gonzalez-Ramella, A Kardus-Urueta, Julia Palma, H Baldomero, D Ubidia, Ernesto Fanilla
Publikováno v:
Bone Marrow Transplantation. 52:798-798
Correction to: Bone Marrow Transplantation (2017) 52, 671–677; doi:10.1038/bmt.2016.361; published online 23 January 2017 Since the online publication of this article, the authors realised there were errors in the legends for Figures 1 and 2. The o
Autor:
D Lerner, M Bonamino, B Barone, I Zalcberg, R Byington, Liege Maria Abreu de Carvalho, D. G. Tabak, Vivian Naziaseno Pires, Cavalcanti Maciel, Zilton Vasconcelos, H Diamond, J da Matta, L.F. Bouzas, Matheus Pessoa Colares, M. de Lima, R Tavares, C. Andrade
Publikováno v:
Bone Marrow Transplantation. 27:73-78
We investigated the use of 'prophylactic' donor lymphocyte infusions (DLI) containing 1 x 107 CD3+ cells, given at 30, 60 and 90 days post-allogeneic blood and marrow transplantation (BMT), following conditioning with fludarabine 30 mg/m(2)/4 days an